Edinburgh Research Explorer

Inclusion of Alteplase, a new individual medicine, in the 21st List of the World Health Organization Model List of Essential Medicines (EML).

Press/Media: Public Engagement Activities

Description

Alteplase (recombinant tissue Plasminogen Activator, rt-PA), for the Treatment of Acute Ischemic Stroke, has been included in the 2019 WHO Model List of Essential Medicines (EML).

Period19 Jul 2019

Alteplase (recombinant tissue Plasminogen Activator, rt-PA), for the Treatment of Acute Ischemic Stroke, has been included in the 2019 WHO Model List of Essential Medicines (EML).

References

TitleWHO Model List of Essential Medicines (EML)
Media name/outlet21st List WHO Model List of Essential Medicines (EML)
Date of coverage19/07/19
URLView reference

ID: 102581522